Genome Engineering: CRISPR Frontiers
2020-08-19 - 2020-08-22 | Cold Spring Harbor, One Bungtown Road, Cold Spring Harbor, 11724, United States
The specific goal for this meeting is to foster fruitful and creative interactions between researchers interested in applying these systems to genome engineering and related advances in a wide variety of organisms, together with scientists studying the basic biology of CRISPR and related bacterial defense systems.
SCGE Organizers: Jennifer Doudna, PhD, David Liu, PhD
SCGE Speakers: David Liu, PhD

Discovery On Target
2020-09-15 - 2020-09-18 | Sheraton Boston, 39 Dalton Street, Boston, MA, 02199, United States
Discovery on Target (DOT) is the industry’s preeminent event on novel drug targets and technologies for drug discovery professionals. DOT highlights advances in current and emerging “hot” targets and technologies, as well as target validation strategies for the discovery and development of novel therapeutic agents, ranging from biologics to small molecules.

Bioproduction Summit
2020-09-21 - 2020-09-22 | VIRTUAL
Bioproduction Summit brings together industry leaders and biotech experts to discuss most challenging issues, ranging from achieving high productivities to scalable platform processes. In addition to popular therapeutic protein production theme, we will feature topics on tackling current manufacturing challenges in the exponentially growing field of AAV Gene and Cell Therapy. Lessons learned from the CHO cell culture will immensely help the field of AAV. Thus bringing experts from these two fields together will accelerate pace of innovations in the coming years.

RNA Editing and Modifications: From Biology to Therapy
2020-09-30 - 2020-10-02 | VIRTUAL
This virtual conference will bring together leading experts in RNA editing and modifications, technology development, and medicine to present and discuss cutting edge research. We anticipate that participants of this conference will benefit from learning the cutting edge of the rapidly advancing field and help move the field forward by creating collaboration opportunities.

4th Epigenetics and Bioengineering Conference
2020-10-01 | James B. Hunt Jr. Library, 1070 Partners Way, Raleigh, NC, 27606, United States
Fueled by the rapid advancements in both epigenetic research as well as translational gene editing and gene therapy, the EpiBio conferences were established in 2017 as a platform for synthetic biologists developing tools for epigenetic reprogramming.

European Society of Gene and Cell Therapy
2020-10-20 - 2020-10-23 | The Exchange, 150 Morrison Street, Edinburgh, EH3 8EE, United Kingdom
The European Society of Gene and Cell Therapy (ESGCT) promotes basic and clinical research in gene therapy, cell therapy, and genetic vaccines by facilitating education, the exchange of information and technology and by serving as a professional adviser to stakeholder communities and regulatory bodies in Europe.

North American Cystic Fibrosis Conference
2020-10-20 - 2020-10-24 | Cystic Fibrosis Foundation, 4550 Montgomery Ave, Bethesda, MD, 20814, United States
The mission of the Cystic Fibrosis Foundation is to cure cystic fibrosis and to provide all people with CF the opportunity to lead long, fulfilling lives by funding research and drug development, partnering with the CF community, and advancing high-quality, specialized care.

RNA at the Bench and Bedside II
2020-11-10 - 2020-11-13 | Ionis Conference Center, 2850 Gazelle Court, Carlsbad, CA, 92010, United States
Burgeoning knowledge about the RNA world is opening up new opportunities to understand disease and develop therapeutic and diagnostic interventions. As RNA therapeutics continue to change the face of clinical practice, this conference explores progress in our understanding of the numerous roles of RNAs in cellular functions and diseases and efforts to translate advances in basic science into safer and more efficacious therapies, with a particular emphasis this year on clinical advances in cardiovascular and metabolic disease.

AASLD - The Liver Meeting 2020
2020-11-12 - 2020-11-17
AASLD is the leading organization of scientists and health care professionals committed to preventing and curing liver disease. We foster research that leads to improved treatment options for millions of liver disease patients. We advance the science and practice of hepatology through educational conferences, training programs, professional publications, and partnerships with government agencies and sister societies.

CRISPR 2.0
2020-11-16 - 2020-11-19 | VIRTUAL
CRISPR 2.0 is the industry-leading meeting dedicated to answering this question by showcasing only the latest and greatest innovations in CRISPR technology, from the potential of prime editing through to epigenome editing to treat chronic pain.
SCGE Member Speakers: Amr Abdeen, PhD and Niren Murthy, PhD

Neurodegenerative Diseases: Biology & Therapeutics
2020-12-01 - 2020-12-05 | Cold Spring Harbor, One Bungtown Road, Cold Spring Harbor, 11724, United States

62nd ASH Annual Meeting & Exposition
2020-12-04 - 2020-12-08 | San Diego Convention Center, 111 W Harbor Dr, San Diego, CA, 92101, United States
Attend the world’s most comprehensive hematology event of the year for an invaluable educational experience and the opportunity to review thousands of scientific abstracts highlighting updates in the hottest topics in hematology.

Keystone: Chromatin Architecture in Development and Human Health
2021-02-20 - 2021-02-25 | Fairmont Banff Springs, 405 Spray Ave, Banff, alberta, T1L 1J4, Canada
This conference will encompass themes of chromatin mechanisms, including DNA and RNA modifications, histone modifications, ATP-dependent nucleosome remodeling complexes, histone variants, chaperones and others, as they intersect with cell identity, cellular and transgenerational memory, with genome function, with nuclear structure, and with biological questions and disease implications.

Keystone: Epigenetics, Chromatin, Development and Disease
2021-02-20 - 2021-02-25 | Fairmont Banff Springs, 405 Spray Ave, Banff, alberta, T1L 1J4, Canada
MEETING CANCELED
The mechanisms underlying nucleosome- and chromatin-based functional control of genomes are studied very broadly across biological systems and at an increasing rate. Additionally, the research being conducted in this field is important as it ultimately impacts and informs basic biology, as well as also contributing to a translational importance in human disease. Therefore, this conference will encompass themes of chromatin mechanisms, including DNA and RNA modifications, histone modifications, ATP-dependent nucleosome remodeling complexes, histone variants, chaperones and others, as they intersect with cell identity, cellular and transgenerational memory, with genome function, with nuclear structure, and with biological questions and disease implications. The topics will also encompass newly emerging technologies and computational approaches to study chromatin and nucleosome structure, function and genomic location. This conference is being held jointly with Chromatin Architecture in Development and Human Health, which will focus on 3D genomics. There will be a joint Keynote speaker, as well as joint sessions. By pairing these two conferences together, it is anticipated that there will be a strong interest from researchers and scientists who are working in these fields.

Rare Disease Day at NIH 2021
2021-02-28 - 2021-03-01 | VIRTUAL
Rare Disease Day® takes place worldwide, typically on or near the last day of February each year, to raise awareness among policymakers and the public about rare diseases and their impact on patients’ lives. Each year, NCATS and the NIH Clinical Center sponsor Rare Disease Day at NIH as part of this global observance. Rare Disease Day at NIH aims to raise awareness about rare diseases, the people they affect, and NIH research collaborations underway to address scientific challenges and to advance new treatments.
SCGE Speaker: Jennifer Doudna, PhD

Keystone: Precision Engineering of the Genome, Epigenome and Transcriptome
2021-03-07 - 2021-03-10 | VIRTUAL
Over the last several years, new genome engineering tools have revolutionized the ability to interrogate biological systems, engineer innovative biotechnologies, and model and treat human disease. The genome engineering field continues to evolve at a frenzied pace, including both the development of new fundamental tools and their application to addressing societal needs. This Keystone Symposium will cover this spectrum of advances, including the most recent technological innovations in genome, epigenome, and transcriptome precision engineering.
SCGE Organizer: Charles Gersbach, PhD, Aravind Asokan, PhD, James Dahlman, PhD

The American Society of Human Genetics 2021 Virtual Meeting
2021-04-07 08:00 - 17:00 (America/Chicago) | VIRTUAL
The American Society of Human Genetics envisions a future where people everywhere realize the benefits of human genetics and genomics research. We work to advance human genetics and genomics in science, health, and society through excellence in research, education, and advocacy.

American College of Medical Genetics Annual Clinical Genetics Meeting
2021-04-13 - 2021-04-17 | LosAngeles Convention Center, 1201 South Figueroa Street, Los Angeles, CA, 90015, United States
The 2021 ACMG Annual Clinical Genetics Meeting will present both research and clinical topics that promote the science and the practice of clinical genetics and genomics. Sessions will focus on the latest discoveries of the etiology and the pathogenesis of genetic disorders, the latest developments in genetic testing and screening, the laboratory’s role in the diagnosis of genetic disorders, the treatment of genetic disorders in children and adults, the delivery of genetic services, and more.

4th International Conference on CRISPR Technologies
2021-05-01 | VIRTUAL
Presented by the Society for Biological Engineering (SBE), the CRISPR Tech 2020 conference will bring together academics and industry representatives to highlight the cutting edge of these developments and the most immediate technical and societal changes.

Non-Coding RNAs: Biology and Applications
2021-05-10 - 2021-05-14 | Renaissance Palm Springs Hotel, 888 Tahquitz Canyon Way, Palm Springs, CA, 92262-6708, United States
A large number of long non-coding RNAs (lncRNAs) with a surprisingly wide-range of cell-type specific expression profiles are present in human transcriptomes. Emerging evidence points to their critical roles in human physiology and pathology and some are recognized as potential therapeutic targets. However, many seminal questions in regard to their mechanism of action remain largely unexplored. There is a need to understand how different regulatory RNAs are processed and regulated, how they act and function in different physiological and disease contexts, how their essential structural modules are built, organized, and interact with proteins and other RNAs in the cell to carry out their functions. We also need to elucidate how the fundamental biology of regulatory RNA can be translated to therapeutic approaches. At this conference, we aim to bring together scientists who study the basic biology of diverse types of ncRNA molecules from generation and processing, structure, mechanisms of action to functional significance in different model organisms, as well as those who develop cutting-edge RNA technologies, biomarkers and medicines for translational purposes. We anticipate that this conference will provide an integrated platform for scientists to communicate the latest available innovative technologies and methodologies that will speed up the exploration of both fundamental regulatory RNA biology and translational applications.

ASGCT 24th Annual Meeting
2021-05-11 - 2021-05-14 | VIRTUAL
ASGCT 24th Annual Meeting
Join Jennifer Doudna, Ph.D., for a Fireside Chat
We’re excited to announce that Jennifer A. Doudna, Ph.D., the co-recipient of the 2020 Nobel Prize in Chemistry, will join us for a live fireside chat on the first day of the 24th Annual Meeting!
Dr. Doudna is the Li Ka Shing Chancellor’s Chair and a professor in the departments of chemistry and of molecular and cell biology at the University of California, Berkeley. She and Emmanuelle Charpentier, Ph.D., received the Nobel Prize in October for their 2012 discovery of the genome-editing tool CRISPR-Cas9.

Therapeutic Strategies for Large Protein Coding
2021-05-13 08:00 - 2021-05-14 16:00 | VIRTUAL
Usher 1F Collaborative is pleased to announce our scientific research conference, Therapeutic Strategies for Large Protein Coding Genes in Usher Syndrome.
SCGE Organizer: Elliot Chaikof, PhD
SCGE Speakers: Kris Saha, PhD, David Liu, PhD, Erik Sontheimer, PhD

International Conference on Genome Evolution
2021-05-17 - 2021-05-18 | VIRTUAL
International Conference on Genome Evolution aims to bring together leading academic scientists, researchers and research scholars to exchange and share their experiences and research results on all aspects of Genome Evolution. It also provides a premier interdisciplinary platform for researchers, practitioners and educators to present and discuss the most recent innovations, trends, and concerns as well as practical challenges encountered and solutions adopted in the fields of Genome Evolution

The 15th International Adenovirus Meeting
2021-05-18 - 2021-05-22 | Beatriz Toledo Hotel, Concilios de Toledo St, Toledo, Spain
Adenoviruses are associated with gastroenteritis, conjunctivitis, respiratory and urinary tract infections which in general have low clinical relevance. However, they can cause severe pathologies, even life-threatening, in immunosuppressed individuals. There is no efficient treatment for adenovirus infections approved so far.
Adenoviruses can also produce serious disease in poultry and other domestic animals, resulting in economic losses. Remarkably, adenoviruses are also the most widely used vectors in the clinical gene therapy field.
Many groups are working to modify the natural properties of adenoviruses and turn them into tools for vaccination, gene transfer, or oncolysis.
The International Adenovirus Meeting is the gathering point for scientists interested in all aspects of adenovirus infection. Worldwide experts share their ideas and latest results on adenovirus detection in nature; their clinical impact; their uses in virotherapies; assembly of the infectious particle; and interaction with the host.

RNA 2021
2021-05-25 - 2021-06-05 | VIRTUAL
The 26th Annual Meeting of the RNA Society will be a Virtual Meeting, from May 25 to June 5, 2021.
SCGE Speaker: Jennifer Doudna, PhD

GECT 2021
2021-05-29 - 2021-05-31 | Grand Link Hotel, No. 42 Chuanshan Road, Guilin City
Int’l Conference on Gene Editing and CRISPR Technologies (GECT 2021) will be held from May 29-31, 2021 in Guilin, China. GECT 2021 will cover issues on Biomedicine, Clinical Application of Gene Editing,CRISPR Systems and CRISPR Technologies,Effective Delivery for Genes in Vitro,Gene Knock In and Genomic Screening,Genome Engineering and DNA repair,Single Base Editing, etc. It dedicates to creating a stage for exchanging the latest research results and sharing the advanced research methods.

Histone and DNA Modifications
2021-05-30 - 2021-06-04 | Mount Holyoke College, 50 College Street, South Hadley, MA, 01075, United States
The description for this conference is being developed by the conference chairs. Please check back regularly for updates to this information.

CRISPR 2020
2021-06-01 - 2021-06-10 | VIRTUAL
The Paris CRISPR 2020 meeting has been cancelled.
The CRISPR 2021 meeting will be organized virtually
from June 1 to 10, 2021.
Mark your calendar!

Gene-Targeted Therapies: Early Diagnosis and Equitable Delivery
2021-06-03 12:00 - 16:30 | VIRTUAL
Currently, technological developments are offering the hope of new therapies for individuals with rare disease at a pace that has the potential for significantly challenging the existing infrastructure for efficient, effective, and equitable delivery. It is important therefore, to plan and be prepared for these challenges. Changes need to be implemented to improve the process of getting more treatments to more patients, more quickly.
June 3rd will focus on defining:

Who are the individuals that could benefit from gene-targeted therapies – now and in the future?

What novel approaches are needed to enable development of gene-targeted therapies for all genetic rare diseases – now and in the future?

When is the optimal time to identify individuals who could benefit from gene-targeted therapies (e.g., newborn screening)

Neurodegenerative Diseases: Genes, Mechanisms and Therapeutics
2021-06-05 - 2021-06-09 | VIRTUAL
This conference aims to provide an integrated discussion of the latest advances in research and therapeutic development for neurodegenerative diseases. Our goals are to focus on the roles of genetic risk factors and their contributions to glial and neuronal health in the aging brain, the biophysical properties of protein misfolding and the propagation of disease-specific proteinopathy, the role of intracellular vesicular trafficking in disease pathogenesis, new insights into the diverse role of glia, innate immunity and microbiomes in neurodegeneration, and novel therapeutic approaches that specifically target each of the novel biological areas. We anticipate that this conference will stimulate more discussions and promote new collaborations among scientists in the academia and industry that ultimately lead to new therapeutic targets to combat neurodegenerative diseases.
